Severe, long-standing DME with cystoid changes, subretinal detachment, and high inflammatory cytokine burden tends to respond better to dual ANG2/VEGF-A inhibition than VEGF monotherapy. Faricimab ...

A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the ...

Long-term use of continuous positive airway pressure (CPAP) slowed the progression of eye disease in sleep apnea patients with non-proliferative diabetic retinopathy, a small randomized study showed, ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

You may not notice any vision changes with background diabetic retinopathy. Treatment isn’t necessary, but improving blood sugar management can help prevent this complication from getting worse. In ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Diabetic retinopathy is an irreversible condition that damages the eye’s retina and can lead to vision loss. It occurs as a potential complication of diabetes from prolonged periods of hyperglycemia.

Diabetic retinopathy is an eye condition that can cause vision changes and vision loss. There are four stages of diabetic retinopathy based on the findings of a dilated eye exam. Diabetic retinopathy ...

Among 34,239 matched pairs, the risk of incident nonproliferative diabetic retinopathy was not different between patients taking empagliflozin or DPP-4 inhibitors (HR 1.04, 95% CI 0.94-1.15) over a ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...